WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.

个人基因组检测与分析服务，包括祖源家系，尼安德特人基因，遗传疾病，健康风险，运动营养，药物代谢等，还有活跃的用户社区和面向开发者的开放平台。

芜湖市海青食品有限公司海青食品专注于食品生产、加工、销售及食品进出口业务20多年，秉持“特色化、规模化、市场化、高效化、品牌化”的经营理念，着力拓展产品种类，扩大产销规模，经济效益迅速提高。2021年和2022年在新冠病毒肆虐，生产和市场遭受冲击的情况下，通过“内强品质，外拓市场”，2021年实现销售收入5053.64万元，2022年实现销售收入8000多万元。企业经营规模和效益达到市内同行业的先进水平。

专业供应食品安全类抗原抗体，宠物疫病类抗原抗体，各类检测试纸卡、试剂盒，有成品和大板供应，质量稳定效价高,价格优惠，欢迎采购和批发！

UD01多功能新冠病毒消毒喷雾枪，是南通优狄旺贸易有限公司采用贺正科技有限公司的PCT专利技术为核心，只添加盐和水然后用电化学的方式生成安全无污染的消毒液、除菌水，产品融合了新冠病毒消杀、消毒、杀菌、除臭、防霉、去农药残留、去甲醛、除螨、去除过敏源等多场景应用，满足家庭空间和公共空间的消毒消杀。UD01以“加水和盐即可消毒的黑科技”，为每一个家庭消灭病毒，全面守护国民呼吸安全与健康。